REVIEW article
Front. Endocrinol.
Sec. Developmental Endocrinology
Non-medical use of exogenous testosterone and anabolic–androgenic substances in young men: health, psychological, and fertility consequences
Provisionally accepted- 1Pomeranian Medical University, Szczecin, Poland
- 2Provincial Hospital, Poznań, Poland
- 3Uniwersytet Szczecinski, Szczecin, Poland
- 4Endocrinology Clinic, Sedimed Medical Centre, Szczecin, Poland
- 5Pomorski Uniwersytet Medyczny w Szczecinie, Szczecin, Poland
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The non-medical use of exogenous testosterone and other anabolic–androgenic steroids (AAS) has increased substantially in recent years, particularly among young men engaged in recreational strength training. Although often perceived as a means of enhancing muscle mass and physical performance, this practice represents a growing public-health concern due to its wide-ranging endocrine, reproductive, and multisystem adverse effects. This narrative review synthesizes current international evidence on the non-medical use of testosterone and AAS in non-professional athletic settings, with a primary focus on endocrine disruption and reproductive health. The review outlines the classification of commonly used anabolic–androgenic compounds, discusses their pharmacological mechanisms of action, and integrates clinical, experimental, and epidemiological data on associated adverse outcomes. Particular attention is given to suppression of the hypothalamic–pituitary–gonadal axis, impaired spermatogenesis, fertility disturbances, and the potential for long-term or persistent endocrine sequelae. In addition, psychological and behavioral factors contributing to AAS use—including muscle dysmorphia, social pressure, and body-image concerns—are discussed as important modulators of risk. The review also addresses current clinical approaches to the management of AAS-related complications, including strategies aimed at hormonal recovery and restoration of reproductive function. By presenting a comprehensive, mechanistic, and clinically oriented overview, this article highlights the need for increased awareness among clinicians and underscores priorities for future research and preventive interventions in endocrine and reproductive health.
Keywords: Anabolic–androgenic steroids, endocrine disruption, Hypogonadism, hypothalamic–pituitary–gonadal axis, male infertility, testosterone misuse, Young men
Received: 05 Jan 2026; Accepted: 16 Feb 2026.
Copyright: © 2026 Kowalik, Harasny, Kaliczyńska, Reweda-Kwiatkowski, Starzyński, Pawlak, Waloryszak, Ptak, Modrzejewski and Lisman. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Dagmara Lisman
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
